Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Cannara Biotech Inc T.LOVE

Alternate Symbol(s):  LOVFF

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers.... see more

Recent & Breaking News (TSX:LOVE)

Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026

GlobeNewswire 4 days ago

Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange

Newsfile March 19, 2026

Cannara Biotech Inc. (LOVE) Opens the Market

Newsfile March 17, 2026

Cannara Announces Graduation to the Toronto Stock Exchange

GlobeNewswire February 26, 2026

Cannara to Host Investor Webcast on February 19th, 2026

GlobeNewswire February 12, 2026

Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced at C$2.10 per Common Share 

GlobeNewswire February 4, 2026

Cannara Announces Conditional Approval to List on the Toronto Stock Exchange

GlobeNewswire January 28, 2026

Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy

GlobeNewswire January 26, 2026

Cannara Achieves OTCQX Qualification and Announces Release of Fiscal Q1 2026 Financial Results on January 26, 2026

GlobeNewswire January 14, 2026

OTC Markets Group Welcomes Cannara Biotech Inc. to OTCQX

GlobeNewswire January 14, 2026

Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch

GlobeNewswire January 2, 2026

Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings

GlobeNewswire November 24, 2025

Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

GlobeNewswire November 17, 2025

Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion

GlobeNewswire October 7, 2025

Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance

GlobeNewswire October 2, 2025

Cannara Announces Grant of Options and RSUs

GlobeNewswire September 1, 2025

Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield

GlobeNewswire August 21, 2025

Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

GlobeNewswire August 14, 2025

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

GlobeNewswire July 28, 2025

Cannara Secures 5 Key Listings in Québec's New Vape Cartridge Category Including to be Released Live Rosin Vapes

GlobeNewswire July 24, 2025